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Abstract Neurological symptoms of acute liver failure (ALF)
reflect decreased excitatory transmission, but the status of ALF-
affected excitatory synapse has not been characterized in detail.
We studied the effects of ALF inmouse on synaptic transmission
and plasticity ex vivo and its relation to distribution of (i) synaptic
vesicles (sv) and (ii) functional synaptic proteins within the syn-
apse. ALF-competent neurological and biochemical changes
were induced in mice with azoxymethane (AOM).
Electrophysiological characteristics (long-term potentiation,
whole-cell recording) as well as synapse ultrastructure were eval-
uated in the cerebral cortex. Also, sv were quantified in the
presynaptic zone by electron microscopy. Finally, presynaptic
proteins in the membrane-enriched (P2) and cytosolic (S2) frac-
tions of cortical homogenates were quantitated by Western blot.
Slices derived from symptomatic AOM mice presented a set of
electrophysiological correlates of impaired transmitter release in-
cluding decreased field potentials (FPs), increased paired-pulse
facilitation (PPF), and decreased frequency of spontaneous and
miniature excitatory postsynaptic currents (sEPSCs/mEPSCs)
accompanied by reduction of the spontaneous transmitter
release-driving protein, vti1A. Additionally, an increased number
of sv per synapse and a decrease of P2 content and/or P2/S2 ratio
for sv-associated proteins, i.e. synaptophysin, synaptotagmin,
and Munc18–1, were found, in spite of decreased content of
the sv-docking protein, syntaxin-1. Slices from AOM-treated
asymptomatic mice showed impaired long-term potentiation
(LTP) and increased PPF but no changes in transmitter release
or presynaptic protein composition. Our findings demonstrate
that a decrease of synaptic transmission in symptomatic ALF is
associated with inefficient recruitment of sv proteins and/or im-
paired sv trafficking to transmitter release sites.
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Introduction
Neuropsychiatric symptoms of acute or chronic liver failure (ALF
or CLF), collectively defined as hepatic encephalopathy (HE), are
associated with a decline of excitatory neurotransmission [1–3].
Present knowledge of the electrophysiological andmolecular cor-
relates of ALF- or CLF-affected synapse is confinedmostly to the
postsynaptic events related to altered Glu receptor-mediated sig-
naling pathways [4] and/or synaptic plasticity, i.e., long-term po-
tentiation (LTP) and LTD [5], while the status of the presynaptic
region involved in neurotransmitter release has remained unat-
tended. A few earlier reports have dealt with alterations in the
synaptic events in brain preparations treatedwith ammonia,which
is a major neurotoxin implicated in HE [6], emphasizing the role
of postsynaptic changes [7–10]. However, the observations were
confined to short-term effects (seconds to minutes), which
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cannot be considered representative for the progression of
ALF symptoms lasting for hours to weeks. In this study, there-
fore, we address the question whether and to what extent ALF
disturbs the functional and structural integrity of the presyn-
aptic neurotransmitter release machinery in addition to post-
synaptic changes. We therefore measured expression and dis-
tribution of presynaptic proteins including (i) the integral ves-
icle proteins synaptophysin and synaptotagmin; (ii) a member
of the Sec1/Munc18-like protein family Munc-18-1; (iii) an
integrated SNARE protein syntaxin-1; and (iv) vt1 interactor
1a (vti1a) protein, which characterizes vesicles driving spon-
taneous release [11–13]. The response of presynaptic proteins
to ALF was compared to that of the constituents of the post-
synaptic complex active in signal transduction, NMDA sub-
unit NR1, PSD95, and the neuronal form of nitric oxide syn-
thase (nNOS). The analysis was carried out in mice in which
ALF was induced with a hepatotoxin, azoxymethane (AOM),
and was preceded by thorough behavioral, biochemical, and
neurophysiological characterization of the model. The results
presented in Table 1 and Figs. 1 and 2 confirm and extend the
findings by others that the mouse AOM model is a valid mod-
el of acute HE in humans [14–16].
Cerebral cortical slices derived from AOM-treated asymp-
tomatic and symptomatic mice were subjected to the electro-
physiological analysis of field potentials (FPs), including
paired-pulse facilitation (PPF) ratio, parameters characterizing
excitability of pyramidal neurons, and spontaneous excitatory
postsynaptic currents (sEPSCs) as well as miniature excitatory
postsynaptic currents (mEPSCs).
Growing evidence that liver failure affects synaptic plastic-
ity and that Glu release plays a crucial role in driving the
postsynaptic events [17] prompted us to assess long-lasting
activity-dependent changes in synaptic efficiency, known as
LTP. LTP underlies multiple forms of synaptic plasticity in the
brain [18]. Analysis of the morphological and biochemical
status of the synapse focused on the neurotransmitter release
apparatus. Ultrastructural assessment of the presynaptic zone
comprised the size and content of sv. Next, we examined the
content and distribution between the cytosolic- and
membrane-enriched compartments of the cerebral frontal
cortex of the abovementioned representative presynaptic and
postsynaptic proteins.
Material and Methods
AOM Model of Acute Liver Failure in Mice
All experiments were performed with agreement of local an-
imal ethical committee in Warsaw in accordance with EC
Directive 86/609/EEC. Male C57BL/6 mice (animal colony
of the Mossakowski Medical Research Centre, Polish
Academy of Sciences in Warsaw), body weight 30.0 ± 5.1 g,
were subjected to a hepatotoxic insult by single, intraperito-
neal AOM injection at 100 mg/kg b.w. The mice had free
access to water and chow and were housed in constant tem-
perature, humidity, and 12-h light-dark cycling. If not other-
wise stated, experiments were performed in the asymptomatic
stage, 4 h after AOM injection, and symptomatic stage, 18 h
after AOM injection. The selection of the time points was
based on the neurological performance of mice.
Table 1 Increased concentration of cytokines, ammonia, and activity
of liver damage marker enzymes in serum of control and AOM mice
Con AOM
IL-6 (pg/ml) 10.0 ± 2.2 214.5 ± 34.5*
TNF-α (pg/ml) 3.1 ± 0.2 14.7 ± 1.8*
AST (IU/I) 172.4 ± 30.6 805.4 ± 92.2*
ALT (IU/I) 46.5 ± 6.1 559.0 ± 52.8*
Ammonia (mg/ml) 0.0052 ± 0.0011 0.0140 ± 0.0010*
*p < 0.05 vs. Con; n = 6
Fig. 1 Novel-cage activity and neurological assessment. a Shorter
distance traveled by AOM-injected mice shortly after placing into a
new cage; **p < 0.01, n = 9. b Decreased neurological score following
AOM injection. Asterisk indicates p < 0.05 vs. the results of the previous
session (2 h earlier), and hashtag indicates p < 0.05 (p < 0.01) vs. 4-h-
earlier session; n = 12. Results are means ± SEM
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Activity Assessment
For activity assessment, immediately after AOM (n = 11) or
saline (n = 5) injections, the mice were placed individually in
novel cages (43 × 27 × 15 cm), with fresh bedding, covered by
a metal 1 × 1-cm grid to allow observation from above. The
experiment room was illuminated by dim red light. The ani-
mals were recorded by an infrared acA1300-60NIR camera
(Bassler AG, Germany) for 4 h, and the activity was measured
using Ethovision XT 10 (Noldus Information Technology,
Netherlands).
Neurological Assessment
Neurological decline was determined in a group of mice
(n = 12) by measuring the corneal reflex, pinna reflex, vibris-
sae reflex, startle reflex, righting reflex, and postural reflex
[16, 19], with each given a score of 0 (no reflex evident), 1
(weak or delayed reflex), or 2 (regular reflex), resulting in a
neurological score in the range of 0 to 12. The reflexes were
measured every 2 h after AOM injection. Corneal reflex was
assessed by touching the eye with saline-soaked cotton appli-
cator and observing a blink response [14, 20]. To determine
pinna reflex, the earlobe was touched with a cotton rod and ear
retraction was observed [20, 21]. To assess vibrissae response,
the whiskers were brushed and reactional headmovement was
observed [21, 22]. Startle reflex was tested by presenting a
sudden, unexpected noise and evaluating the reaction of the
animal [15, 23]. Righting reflex was determined by placing
the mice on their backs and assessing how fast they right
themselves [20, 24]. Postural reflex was tested by placing
the mice individually in a cage without bedding and rapidly
moving it in cardinal directions and judging how the animals
try to keep their balance [20, 25].
Biochemical Blood Analyses
Enzymatic Determination of Liver Enzymes and Ammonia
in Serum
Blood was collected into Eppendorf and after the formation of
a clot, centrifuged at 8000×g for 6 min. Then using enzymatic
tests for ammonia, alanine aminotransferase (ALT) and aspar-
tate aminotransferase (AST), the absorbance were measured at
a wavelength of 340 nm after mixing probe with reagent and
every 60 s for 2 min in 37 °C. Using an appropriate model,
based on the difference in absorbance in time (Δabs/min),
results are expressed as IU/l.
Cytokine IL-6 and TNF-α Concentrations in Serum
Blood was collected into Eppendorf and after the formation of
a clot, centrifuged at 6500×g for 10 min. The microsphere-
based immunoassay (cytometric bead array (CBA); BD
Biosciences) was performed in accordance to the commercial
protocol with modifications [26]. Briefly, six microsphere
populations with distinct fluorescence intensities were dyed
with proprietary dyes (emission 650 nm). These beads were
coated with capture antibodies against cytokines and mixed
with recombinant standards or serum and the phycoerythrin
(PE)-conjugated cytokine antibodies (emission 585 nm) to
form sandwich complexes. The instrument setup was per-
formed with CaliBRITE beads, and the cytometer setup beads
(BD) were done according to the manufacturer’s instructions;
2000 events were measured and analyzed. A monomeric mi-
crosphere population was gated on forward and side scatters.
Data were analyzed in two-color fluorescence dot plots
representing the different microsphere populations (emission
650 nm) and the cytokine concentration (according to PE
emission 585 nm). Mean fluorescence intensity values were
Fig. 2 Metabolite analysis by 1H magnetic resonance spectroscopy
technique and cerebral cortex microdialysis of AOM mice. a
Spectrometric analysis revealed ALF-specific changes in cerebral cortex
of AOM mice. Asterisk indicates p < 0.05 vs. Con; n = 12. Analyzed
metabolites Ala alanine, Asp aspartic acid, Cr creatine, PCr
phosphocreatine, GABA gamma-aminobutyric acid, Gln glutamine, Glu
glutamate, PCh phosphocholine, GSH glutathione, INS myo-inositol, Lac
lactate, NAA N-acetylaspartate, Tau taurine, GPC glycerophosphocholine,
NAAG N-acetylaspartylglutamate. b Extracellular glutamate
concentration, as determined in microdialysates from freely moving
mice, was significantly elevated after AOM administration; n = 4.
Results are means ± SEM
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collected. Four-parametric logistic calibration curves were
used, and results were expressed as pg/ml.
Metabolite Analysis by 1H Magnetic Resonance
Spectroscopy Technique and Cerebral Cortex
Microdialysis of Symptomatic AOM Mice
1H Magnetic Resonance Spectroscopy Acquisition
and Processing
To obtain the spectra of brain metabolites, localized proton
spectroscopy (Biospec 70/30USR) at short echo was per-
formed using PRESS sequence (TR/TE = 2000/20 ms, 512
averages, 2048 points, scan time = 17 min) with VAPOR
water suppression, the outer volume suppression, and frequen-
cy drift correction (flip angle 5°). Eddy current correction was
performed at the scanner. Each measurement was carried out
in two separated volumes of interest (VOI). The VOI
(4 × 2 × 1.5 mm3) encompassed the frontal cortex. Linear
and second-order global shims were adjusted with
ADJ_1st_2nd_order protocol. Afterwards, linear and
second-order local shims were automatically adjusted with
FASTMAP in a cubic volume which contained the volume
of interest region (4 × 4 × 4 mm3 for the frontal cortex). The
unsuppressed water line width was typically maintained at
around 9–12 Hz.
Metabolite concentrations were determined using a linear
combination analysis method LCModel [27] (http://www.s-
provencher.com/pages/lcmodel.shtml). The unsuppressed
water signal measured from the same volume of interest was
used as internal reference for absolute metabolite
quantification. Metabolite concentrations are reported in
institutional unit (IU). The spectrum signal to noise ratio was
typically at around 12–25.
Microdialysis on Freely Moving Mice
Micewere anesthetized with isoflurane (3.5% in air), placed in
a stereotaxic frame, and kept asleep at a flow rate of 1.5%. The
head was shaved and decontaminated by 70% ethanol, and
two 1.2-mm-diameter holes were drilled, first at coordinates
AP −0.5, ML +0.5, in which skull screw was inserted, and
second at coordinates AP +2.0, ML −0.5, DV −0.5 according
to the atlas [28], in which a guide cannula was inserted. Guide
cannula was implanted at a depth of 0.5 mm. Skull surface and
guide cannula were secured with dental acrylic cement.
Before arousals, antibiotic (Baytril, 2.5%; 0.2 ml/kg b.w.)
and a painkiller (Ketonal, 2.5 mg/kg b.w.) were subcutaneous-
ly administered. Animals were placed in 21-cm-diameter cy-
lindrical cages with ad libitum access to food and water. One
day after surgery, mice were anesthetized with isoflurane
(3.5% in air) and a probe was implanted. After preparing the
probe in accordance with the instructions, ACSF of the
following composition (in mM): NaCl (130), KCl (5), CaCl2
(2.5), MgSO4 (1.3), KH2PO4 (1.25), NaHCO3 (26), and D-
glucose (10), bubbled with a mixture of 95% O2 and 5% CO2
passes through it. After 1 h in 2.5-μl/h flow, samples were
collected every 40 min (100 μl) for 4 h (six fractions). After
this, AOM was i.p. injected, and after 16 h, samples were
collected every 40 min. All samples were immediately frozen
at −80 °C.
High-Performance Liquid Chromatography Determination
of Glutamate
Glutamate concentration in mice microdialysates was mea-
sured using HPLC with fluorescence detection after derivati-
zation in a timed reaction with o-phthalaldehyde plus
mercaptoethanol, exactly as described earlier [29].
Electrophysiological Studies
The brains were rapidly removed from the skulls and im-
mersed in an ice-cold ACSF of the following composition
(in mM): NaCl (130), KCl (5), CaCl2 (2.5), MgSO4 (1.3),
KH2PO4 (1.25), NaHCO3 (26), and D-glucose (10), bubbled
with a mixture of 95%O2 and 5%CO2. Frontal cortical slices,
400 μm thick, were cut in the coronal plane using a vibrating
microtome (Leica). Slices were stored at 32.0 ± 0.5 °C.
FP Recording and LTP Induction
Individual slices were placed in the recording chamber of an
interface type which was superfused (2.5 ml/min) with a mod-
ified ACSF (temperature 32.0 ± 0.5 °C) containing (in mM)
NaCl (132), KCl (2), CaCl2 (2.5), MgSO4 (1.3), KH2PO4
(1.25), NaHCO3 (26), and D-glucose (10), bubbled with
95% O2 and 5% CO2 (temperature 32.0 ± 0.5 °C). A concen-
tric bipolar stimulating electrode (FHC, USA) was placed in
cortical layer V. Stimuli of 0.033-Hz frequency and duration
of 0.2 ms were applied using a constant-current stimulus iso-
lation unit (WPI). Glass micropipettes filled with ACSF (2–
5 MΩ) were used to record field potentials. Recording micro-
electrodes were placed in cortical layer II/III. The responses
were amplified (EXT 10–2 F amplifier, NPI), filtered (1 Hz–
1 kHz), A/D converted (10-kHz sampling rate), and stored on
PC using the Micro1401 interface and Signal 2 software
(CED). A stimulus-response (input-output) curve was made
for each slice. To obtain the curve, stimulation intensity was
gradually increased stepwise (15 steps; 5–100 μA). One re-
sponse was recorded at each stimulation intensity. Then, stim-
ulation intensity was adjusted to evoke responses of 30% of
the maximum amplitude. LTP was induced by theta burst
stimulation (TBS). TBS consisted of 10 trains of stimuli at
5 Hz, repeated 5 times every 15 s. Each train was composed
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of five pulses at 100 Hz. During TBS, pulse duration was
increased to 0.3 ms.
Whole-Cell Recording
Individual slices were placed in the recording chamber
mounted on the stage of the Axioskop (Zeiss) microscope
and superfused at 2 ml/min with ACSF. Recording pipettes
were pulled from borosilicate glass capillaries (Harvard
Apparatus) using Sutter Instrument P97 puller. The pipette
solution contained (in mM) 130 K-gluconate, 5 NaCl, 0.3
CaCl2, 2 MgCl2, 10 HEPES, 5 Na2-ATP, 0.4 Na-GTP, and 1
EGTA (osmolality 290 mOsm, pH = 7.2). Pipettes had open
tip resistance of approximately 6 MΩ. Pyramidal cells were
sampled from the sites located approximately 2 mm lateral to
the midline and approximately 0.3 mm below the pial surface.
Signals were recorded using the SEC 05LX amplifier (NPI),
filtered at 2 kHz, and digitized at 20 kHz using Digidata
1440A interface and Clampex 10 software (Molecular
Devices).
After obtaining the whole-cell configuration and subse-
quent 10-min stabilization period, the firing characteristics of
the recorded cells were assessed using intracellular injections
of rectangular current pulses of increasing amplitude (duration
400 ms) in the current clamp mode. For each cell, the relation-
ship between injected current intensity and the number of
spikes was plotted. The gain was determined as a slope of
the straight line fitted to experimental data. The threshold
current (Ith) was determined as a current extrapolated at zero
firing rate. To record sEPSCs, neurons were voltage clamped
at −76 mV and synaptic events were recorded for 4 min as
inward currents. To record mEPSCs in some experiments,
1 μM tetrodotoxin (TTX) was added to the ACSF spontane-
ous and miniature EPSCs were detected offline using the au-
tomatic detection protocol (Mini Analysis software,
Synaptosoft Inc.) and subsequently checked manually for ac-
curacy. Data were accepted for the analysis when the access
resistance ranged between 15 and 18 MΩ and it was stable
(<25% change) during recording. The threshold amplitude for
the detection of an EPSC was set at 5 pA.
Transmission Electron Microscopy
The animals were anesthetized and perfused through the as-
cending aorta with 2% paraformaldehyde and 2.5% glutaral-
dehyde in 0.1 M cacodylate buffer, pH 7.4. The cerebral cor-
tex was fixed in the same solution for 20 h (at 4 °C) and placed
in a mixture of 1% OsO4 and 0.8% K4[Fe(CN)6]. Electron
microscopy analysis was performed on 10 sections from each
experimental and control animals. Synapses were classified
according to their morphology. For the analysis, only asym-
metric (i.e., excitatory) synapses were taken into account. Sv
were quantified by counting them in all visible synapses at
each section (in all fields). Sv were counted in specimens from
control and symptomatic AOM animals. The average number
of the vesicles was calculated for each group.
Immunoblotting Analyses
Immediately removed mice brain cortex was isolated on ice,
homogenized in buffer (20 mM Tris-HCl, pH 6.8; 137 mM
NaCl; 2 mMEDTA; 1% Triton X-100; 0.5 mMDTT; 0.5 mM
PMSF; Phosphatase Inhibitor cocktail 1:100; Protease
Inhibitor Cocktail 1:200), and centrifuged at 12000×g for
10 min. To separate P2 and S2 fractions, cortex was homog-
enized in buffer (15 mM Tris-HCl, pH 7.6; 0.25 M sucrose,
1 mM DTT; 0.5 mM PMSF, Phosphatase Inhibitor Cocktail
1:100; Protease Inhibitor Cocktail 1:200) and centrifuged at
1000×g for 10min (4 °C)—P1 fraction. Separated supernatant
was centrifuged at 14000×g for 20 min (4 °C) and S2 fraction
(supernatant) was collected. The pellet, after buffer addition,
was frozen as P2 fraction. Protein concentrations for both
assays were performed using a BCA Protein Assay from
Thermo Scientific (Pierce, Rockford, IL, USA).
The content of synaptic proteins was assessed by immuno-
blotting as previously described [30, 31]. Cortex
homogenates/S2 fraction/P2 fraction were loaded with 15–
30 μg of protein diluted in Laemli buffer per each tissue sam-
ple and loaded in 10% SDS-PAGE gels, then transferred on to
PVDF membrane. The purity of S2 and P2 fractions was fur-
ther analyzed by immunoblotting using antibodies against lac-
tate dehydrogenase (LDH) and cadherin as cytosolic and
membrane fraction markers, respectively. Western blot mem-
branes were blocked in 5% milk and incubated overnight at
4 °C with antibodies (against nNOS, NR1, PSD-95,
synaptophysin, synaptotagmin, syntaxin-1,Munc 18–1, vti1a)
in recommended dilution in 1% milk and then for 1 h in 1%
milk with secondary reagents. The protein bands were visual-
ized with enhanced chemiluminescence, using G-BOX
(Syngene). Data were expressed as fold change in fluorescent
band intensity of target antibody divided byGAPDH, which is
used as a loading control. The values of vehicle or control
groups were used as a baseline and set to a relative protein
expression value of 1. All band intensity quantifications were
analyzed using GeneTools.
Statistical Analyses
An ANOVA followed by Dunnett post hoc test was used to
detect intervals in which significant changes occurred for all
data sets where a parameter was measured across time points
within a treatment. Student’s t test or theMann-WhitneyU test
was applied when two populations of responses were exam-
ined. Error bars represent the SD or SEM, which is specifical-
ly indicated, *p < 0.05, **p < 0.01, and ***p < 0.001.
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Results
Characteristics of the AOM Model
Activity assessment revealed a difference between control and
AOM-injected animals in the distance traveled following plac-
ing in a novel cage (Fig. 1a). Repeated measures ANOVA
showed a strong effect of treatment [F(1,14) = 15.66,
p < 0.01] and testing time [F(5,70) = 23.51, p < 0.001] as well
as treatment × time effect [F(5,70) = 2.47, p < 0.05]. The
activity of both groups gradually decreased; however, AOM
mice started traveling shorter distances as early as 15–30 min
postinjection, as demonstrated by planned comparisons
(p < 0.01 for all time intervals after 0–15 min).
The neurological score at each time point was defined as
the summation of six reflexes, and the average values can be
seen in Fig. 1b. Continuous and significant neurological de-
cline towards coma was observed starting from the sixth hour
following AOM injection, as revealed by Friedman nonpara-
metric analysis (p < 0.001) followed by individual Wilcoxon
comparisons of dependent groups.
AOM injection led to a significant increase in the con-
centration of ammonia and inflammatory cytokines, TNF-α
and IL-6, and activities of liver damage marker enzymes,
ALT and AST in plasma (Table 1). In vivo 1H spectrometric
analysis revealed ALF-specific changes including increase
of Glu/Gln ratio and myo-inositol in cerebral cortex of
AOM-treated mice (Fig. 2a). Extracellular Glu concentra-
tion, as determined in microdialysates from freely moving
mice, started to increase on 17 h after AOM administration
(Fig. 2b).
Stage Dependence of Electrophysiological Responses
of Cortical Slices from AOMMice
FPs, PPF, and LTP
Analyses of FPs revealed no significant differences in the
stimulus-response relationship between slices prepared 4 h
after AOM administration (AOM 4 h) and control prepara-
tions (Fig. 3a). In contrast, in brain slices prepared from mice
with neurological decline (AOM 18 h), the amplitude of FPs
was markedly lowered over a wide range of stimulation inten-
sities (Fig. 4b). Parameters characterizing input-output curves
of FPs, calculated using the Boltzmann fits, are summarized in
Table 2. The mean amplitude of FPs, measured 60–75 min
after delivery of TBS, to induce LTP, was 128.6 ± 4.2% of
baseline in the control asymptomatic group (Fig. 3b) and
141.1 ± 6.1% of in the Con 18-h group (Fig. 4b). LTP was
significantly attenuated in the slices obtained from AOM-
treated animals both in asymptomatic stage (108.5 ± 6.2%;
p < 0.01 vs. Con 4 h; Fig. 3b) and in symptomatic stage
(108.4 ± 3.6%; p < 0.001 vs. Con 18 h group; Fig. 4b).
Despite a lack of changes in the amplitudes of FPs, in slices
obtained from AOM mice at asymptomatic stage, PPF ratio
was significantly increased (Con 4 h 117.6 ± 5.1% vs. AOM
4 h 130.9 ± 4.4%; p < 0.05; Fig. 3c1, c2). PPF was further
increased in slices obtained 18 h after AOM administration
(Con 18 h 121.5 ± 3.5% vs. AOM 18 h 158.3 ± 6.9; p < 0.001;
Fig. 4c1, c2).
Pyramidal Neuron Membrane Excitability
Whole-cell recordings were obtained from layer II/III neurons
exhibiting a regular spiking firing pattern in response to a
depolarizing current pulse (Figs. 3d and 4d). In slices prepared
4 h after AOM administration, the resting membrane potential
of neurons was significantly different from control neurons
(−78.1 ± 0.8 vs. −73.6 ± 0.6 mV, respectively; p < 0.001). A
similar difference existed between neurons in slices prepared
18 h after AOM injection and control cells (−78.6 ± 2.0 vs.
−73.4 ± 0.7 mV, respectively; p < 0.05). The input resistance
of neurons originating from AOM 4 h mice was not different
from that of the control group (143.5 ± 2.8 vs.
151.1 ± 4.7 MΩ, respectively; p = 0.36); however, the input
resistance of neurons originating from AOM 18-h mice was
significantly lower from that of the respective control group
(123.4 ± 11.6 vs. 167.1 ± 12.0 MΩ, respectively; p < 0.01).
Analyses of the relationship between the injected current
and the firing rate (gain; Figs. 3e and 4e) demonstrated that
AOM did not modify the intrinsic excitability of pyramidal
neurons. Neither in slices prepared 4 nor 18 h after AOM
administration, the differences between experimental and con-
trol mice were significant (Figs. 3f and 4f). However, in slices
obtained 18 h after AOM administration, the calculated
threshold current for the generation of the action potential
was significantly higher than in the respective control mice
(Con 18 h; 344.0 ± 27.7 vs. 236.6 ± 17.2 pA; p < 0.01;
Fig. 4g). This effect appears to be related to a markedly lower
membrane resistance of neurons in the AOM 18-h group. In
contrast, the average spike threshold current in the AOM 4-h
mice was not different from the Con 4-h mice (Fig. 3g).
Excitatory Postsynaptic Currents
In the cells originating from the AOM 4-h mice, the mean
frequency of sEPSCs was similar to respective control
(Fig. 3j). Similarly, the mean amplitudes of sEPSCs in the
AOM 4-h mice and in the respective control were not signif-
icantly different (Fig. 3k). However, in the cells originating
from AOM 18-h mice, the mean frequency of sEPSCs was
significantly lower in comparison to that in the cells from
control animals (1.0 ± 0.1 vs. 1.5 ± 0.1 Hz; p < 0.001;
Fig. 4j). AOM, acting for 18 h, also increased the mean am-
plitude of sEPSCs (10.4 ± 0.3 vs. 9.5 ± 0.2 pA; p < 0.05;
Fig. 4k), and additionally, it significantly increased the mean
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decay time constant of sEPSCs (from 4.5 ± 0.2 to 5.9 ± 0.3 ms;
p < 0.001; Fig. 4m). AOM did not alter the mean rise time of
sEPSCs either in the AOM 4-h mice (Fig. 3l) or in the AOM
18-h mice (Fig. 4l).
The effect of Na+ channel blockade on recorded EPSCs
was investigated in separate samples of neurons obtained from
control and AOM-treated mice (Con 4 h vs. AOM 4 h and
Con 18 h vs. AOM18 h). The addition of 1 μMTTX toACSF
Fig. 3 Electrophysiology of ALF-induced changes in cerebrocortical
slices obtained from AOM mice at asymptomatic stage. a–c2 The
effects of AOM on FPs in slices prepared from asymptomatic mice
(AOM 4 h). a The amplitudes of FPs of control (Con 4 h) and AOM
mice (AOM 4 h). b Impairment of LTP. Insets in a, b show the
superposition of averaged FPs recorded in representative experiments at
times indicated by numbers. Arrows in b denote the TBS. c1 Examples of
individual FPs evoked by paired stimuli in slices from control (open
circles) and AOM-treated mice (filled circles). c2 Summary
quantification of the average PPF ratio (±SEM); *p < 0.05. d–g In
slices prepared from asymptomatic mice (AOM 4 h), the basic
electrophysiological properties of layer II/III pyramidal neurons remain
unchanged (apart from the resting membrane potential, see text). d An
example of response of control pyramidal neuron (left trace) and response
of a cell from AOM-treated (AOM 4 h) mouse (right trace) to a
depolarizing current pulse (lower traces). e The injected current vs.
spiking rate relationship in a cell originating from control mouse (open
circles) and in a neuron originating from AOM-treated mouse (filled
circles). Solid lines represent the linear fits to the experimental data. f
The mean gain (±SEM) and g mean firing threshold (±SEM) of
pyramidal neurons prepared from control (white bars; 18 cells; n = 5)
and AOM-treated animals (black bars; 21 cells; n = 5). h–m Lack of
changes in sEPSCs in slices from asymptomatic mice (AOM 4 h). h
Examples of raw records from control neuron (upper pair of traces) and
neuron from AOM mouse (lower pair of traces) recorded before (Con
4 h, AOM 4 h) and after addition of TTX (Con 4 h + TTX, AOM 4 h +
TTX). i The superposition of averages of all individual sEPSCs detected
during 4 min baseline recordings from control neuron (thin line) and a
neuron originating from an AOM-treated mouse (thick line). Bar graphs
illustrate a lack of the influence of AOM on j mean frequency, k mean
amplitude, lmean rise time, andmmean decay time constant of sEPSCs.
In j–m, neurons originating from control mice, error bars represent the
SEM (white bars; 18 cells; n = 5) and AOM-treated animals (black bars;
21 cells; n = 5)
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did not result in significant changes of the mean frequency,
mean amplitude, mean rise, and mean decay time constant of
sEPSCs (Table 3) either in control or in experimental groups.
This finding indicates that in our whole-cell recordings, the
contribution of action potential-induced release of neurotrans-
mitter from presynaptic terminals is negligible.
Ultrastructural Analysis of Cortical Synapses
Electronmicroscopy analysis of the cortex from the symptom-
atic AOM mice showed an increased number of synapses
showing abundance of sv in the presynaptic zone. The num-
bers of sv in randomly selected sections from symptomatic
mice were (~15%) higher than in the control (Fig. 5a, b).
Expression of Synaptic Proteins at Different Stages
of ALF
Presynaptic Proteins
The membrane to cytoplasm content ratio (P2/S2) of pre-
synaptic proteins, synaptophysin and synaptotagmin, were
Fig. 3 (continued)
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decreased by ~50 and ~30%, respectively, in the frontal
cortex of symptomatic mice as compared to the control
and that of Munc 18–1 was increased by ~70% (Fig. 6b).
The P2 fraction content of syntaxin-1 revealed an ~20%
increase, and the level of vti1a protein, which characterizes
vesicles driving spontaneous release, was significantly
decreased (Fig. 6c). In the AOM mice at the asymptomatic
stage, neither the S2 nor the P2 content of synaptophysin
was changed (Fig. 6d). The S2 protein content of
synaptophysin increased gradually between asymptomatic
and symptomatic stages (Fig. 6d). The cytosolic and mem-
brane fraction markers LDH and cadherin were analyzed
Fig. 4 Electrophysiology of ALF-induced changes in cerebrocortical
slices obtained from AOM mice at symptomatic stage. a–c2 The effects
of AOMon FPs in slices prepared from symptomatic mice (AOM18 h). a
The amplitudes of FPs of control (Con 18 h) and AOMmice (AOM18 h).
b Impairment of LTP. c1 Examples of individual FPs evoked by paired
stimuli in slices from control and AOM-treated mice. c2 Summary
quantification of the average PPF ratio (±SEM); ***p < 0.001. Symbols
as in Fig. 3a–c2. d–g In slices prepared from symptomatic mice (AOM
18 h), the excitability of layer II/III pyramidal neurons is reduced. d An
example of response of control pyramidal neuron (Con 18 h) (left trace)
and response of a cell from symptomatic mouse (AOM 18 h) (right trace)
to a depolarizing current pulse (lower traces). e The injected current vs.
spiking rate relationship in a cell from control mouse and in a neuron from
AOM-treated mouse. f The mean gain (±SEM) and g mean firing
threshold (±SEM) of pyramidal neurons prepared from control (23
cells; n = 6) and AOM-treated animals (21 cells; n = 6); **p < 0.01.
Symbols as in Fig. 3d–g. h–m sEPSCs in slices prepared from
symptomatic rats (AOM 18 h). h Examples of raw records from a
control neuron (upper pair of traces) and a neuron from AOM mouse
(lower pair of traces) recorded before (Con 18 h, AOM 18 h) and after
addition of TTX (Con 18 h + TTX, AOM 18 h + TTX). i The
superposition of averages of all individual sEPSCs detected during 4-
min baseline recordings from a control neuron (thin line) and a neuron
originating from anAOM-treated mouse (thick line).Bar graphs illustrate
the effect of AOM on j mean frequency, k mean amplitude, l mean rise
time, and m mean decay time constant of sEPSCs. In j–m, neurons
originating from control mice, error bars represent the SEM (white
bars; 23 cells; n = 6) and AOM-treated animals (black bars; 21 cells;
n = 6); *p < 0.05, **p < 0.01, ***p < 0.001
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by immunoblotting and confirmed a purity of both frac-
tions (Fig. 6a).
Postsynaptic Proteins
Analysis of postsynaptic complex NMDAR/PSD-95/nNOS
revealed ~16, ~40, and ~35% increase of its particular com-
ponents, i.e., NR1 subunit, PSD-95, and nNOS protein, re-
spectively, in P2 fraction from the frontal cortex of symptom-
atic AOM-treated mice (Fig. 7a). Moreover, in the prodromal
stage of AOM, the PSD-95, but not NR1 proteins level, was
increased (Fig. 7b).
Table 2 Effects of the treatment with AOM on parameters
characterizing stimulus-response curves of field potentials
Vmax (Mv) Uh (μA) S Number
Con 4 h 1.19 ± 0.40 23.86 ± 3.20 9.16 ± 4.21 11
AOM 4 h 1.13 ± 0.39 22.77 ± 4.50 8.14 ± 4.10 12
Con 18 h 1.80 ± 0.40 19.38 ± 6.20 8.20 ± 3.59 18
AOM 18 h 1.05 ± 0.36* 27.77 ± 5.04* 7.59 ± 3.10 25
*p < 0.001; AOM 18 h vs. control animals (Con 18 h)
Fig. 4 (continued)
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Discussion
The present study provided an exhaustive description of alter-
ations in synaptic transmission, ultrastructure, and expression
of synaptic transmission-related proteins in the frontal cortex
of mice with ALF. In our hands, the AOMmodel reproduced a
wide spectrum of changes in blood and brain biochemistry as
well as in neurophysiological and behavioral manifestations
of ALF, each reflecting those reported for acute HE in differ-
ent animal ALF models [25, 32–34] and the health status of
patients with ALF [35–37]. Progression of neurological deficit
in AOM-treated mice suggested that ALF could affect and/or
modify information processing in mice frontal cortex and
prompted us to carry out detailed investigations of electro-
physiological properties of pyramidal neurons and excitatory
synapses at the asymptomatic and symptomatic stage. The
results documented that disturbances in neurotransmission co-
incide with impaired neurological status of the animals. At the
asymptomatic stage, no significant changes in most parame-
ters characterizing synaptic transmission, such as FP ampli-
tude and the frequency and amplitude of sEPSCs/mEPSCs,
were evident. However, despite lack of those changes, the PPF
ratio was elevated at this stage. As in PPF, an increase in the
amplitude of the response to the second pulse of a pair is
determined by a presynaptic mechanism involving the resid-
ual calcium signal arising from calcium entry through voltage-
gated calcium channels [38]; this result may indicate that early
effects of ALF, at asymptomatic stage, include disturbances in
calcium-buffering mechanisms within presynaptic terminals.
At the level of neurological status, the PPF ratio was higher
than at the asymptomatic stage; however, this effect was ac-
companied by other marked changes including a reduction in
the frequency of sEPSCs/mEPSCs.
As the number of glutamatergic synapses in the fron-
tal cortex of AOM-treated mice appeared unchanged, the
observed decrease in sEPSC/mEPSC frequency (Fig. 4j)
was most likely due to a decreased probability of release
of glutamate quanta from presynaptic terminals, which
may also underlie a decrease in the amplitude of FPs.
This conclusion is further supported by the finding that
the distribution of synaptophysin, synaptotagmin, and
vti1a proteins was significantly distorted in the symptom-
atic AOM-injected mice.
At the level of neurological status, however, an in-
creased amplitude and a longer decay time constant of
sEPSCs/mEPSCs were also evident. These changes appear
to be of postsynaptic origin, related to the reactivity and
kinetics of ionotropic glutamate receptors and may be re-
lated to observed changes in the postsynaptic complex pro-
teins. Moreover, in the symptomatic AOM-treated mice, a
markedly lower membrane resistance of neurons was evi-
dent. These effects were not related to a direct action of
ammonium ion on neurons [8] as the slices had been
Fig. 5 Electron microscopy of the cerebral cortex of control and AOM-
treated mice at symptomatic stage. a Representative synapses are
indicated by red circles. b Average number of synaptic vesicles at
synapses counted from 50 randomly selected synapses of control
(n = 3) and AOM-treated mice (n = 4); asterisk indicates p < 0.05 vs.
control animals (Con). Results are means ± SEM
Table 3 Comparison of sEPSC and mEPSC parameters in control and
AOM-treated (4 and 18 h) mice
Con 4 h Con 18 h
sEPSCs mEPSCs sEPSCs mEPSCs
Frequency (Hz) 1.1 ± 0.1 1.1 ± 0.1 1.3 ± 0.1 1.3 ± 0.1
Amplitude (pA) 8.4 ± 0.2 8.4 ± 0.2 9.4 ± 0.2 9.3 ± 0.2
Rise (ms) 1.5 ± 0.1 1.5 ± 0.1 1.4 ± 0.0 1.4 ± 0.0
Tau (ms) 6.2 ± 0.3 6.2 ± 0.3 4.6 ± 0.1 4.6 ± 0.1
AOM 4 h AOM 18 h
sEPSCs mEPSCs sEPSCs mEPSCs
Frequency (Hz) 1.1 ± 0.1 1.0 ± 0.1 1.0 ± 0.0 1.0 ± 0.0
Amplitude (pA) 8.9 ± 0.4 8.8 ± 0.4 10.3 ± 0.2 10.2 ± 0.2
Rise (ms) 1.5 ± 0.1 1.5 ± 0.1 1.5 ± 0.1 1.5 ± 0.1
Tau (ms) 6.8 ± 0.2 6.8 ± 0.2 5.9 ± 0.1 5.9 ± 0.1
Data are presented as the mean ± SEM
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incubated for several hours in the ACSF before recordings
began.
Quantification of sv and analysis of changes in the distribution
of synaptic proteins further confirmed the contribution of presyn-
aptic modifications to ALF-induced changes in neurotransmis-
sion in the model. The number of sv per synapse was found
increased, which is consistent with the decrease of membrane-
to synaptoplasm content ratio of synaptophysin and synaptotag-
min, suggesting a decreased efficiency of vesicle trafficking to
the membrane. It is tempting to speculate that increased associa-
tionwith themembranes of the fusion proteinMunc-18-1 and the
docking protein syntaxin-1 may reflect their response of the de-
ficient supply of vesicles for interaction with these proteins.
However, analysis of the expression and positioning of many
other components of the dockingmachinery, not considered here,
including Munc-13, calcium-dependent activator protein for se-
cretion, SNAP-25, and synaptobrevin-2 are needed to verify this
speculation. The vps10p tail interactor 1a (vti1a) protein, acting
together with vesicle-associated membrane protein 7, character-
izes vesicles driving spontaneous release [11]. Since the postsyn-
aptic currents measured corresponded to mEPSCs, a product of
activity-independent, spontaneous release of glutamate from
Fig. 6 Protein content of selected
presynaptic proteins. a Purity of
S2 and P2 fraction. b
Synaptophysin, synaptotagmin-1,
and Munc 18–1 protein contents
in the cerebral cortex of control
and symptomatic AOM-treated
mice shown as membrane (P2) to
cytosolic (S2) fraction ratio (P2/
S2) (n = 8), followed by
representative electrophorograms.
c Syntaxin-1 and vti1A protein
contents in membrane fraction
(P2) in control and symptomatic
AOM-injected mice (n = 8),
followed by representative
electrophorograms. d Changes in
synaptophysin protein content in
cytosolic (S2) and membrane
fraction (P2) at prodromal and
symptomatic stage of ALF
(n = 6), followed by
representative electrophorograms.
Asterisk indicates p < 0.05 vs.
control animals (Con). Results are
means ± SEM
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presynaptic terminals, the ALF-related decrease of vti1a expres-
sion may therefore be considered as a likely, albeit perhaps not
the only cause of the inhibition of mEPSCs.
In our study, slices from AOM-treated mice with early,
minor neurological deficits and from the symptomatic animals
showed impaired LTP. Impairment of LTP has been repeatedly
demonstrated in chronic liver failure [4, 39], the studies most-
ly focusing on the role of modulation of the NMDA-sGC-
nNOS-NO-cGMP pathway [5, 40, 41]. The present study
documents, to our knowledge for the first time, that al-
though the expression of proteins critical for postsynaptic
activity (the NR1/PSD-95/nNOS complex) was in-
creased, LTP was nevertheless impaired. Thus, mecha-
nisms operating beyond that complex appear to underlie
the observed effect. It is conceivable that they may in-
volve observed increase in the levels of proinflammatory
cytokines, IL-6 and TNF-α, as activation of the cytokine
network in the brain has been shown to be involved in
LTP [42].
In conclusion, the here presented data demonstrate that
symptomatic ALF is associated with decreased synaptic trans-
mission which appears to be related to derangements of pre-
synaptic proteins, resulting in inefficient sv docking to the
synaptic membrane. By contrast, the content of postsynaptic
proteins is enhanced, which may reflect a response to de-
creased presynaptic activity. Evidently, the postsynaptic mod-
ifications, occurring during symptomatic ALF, appear insuffi-
cient to provide effective compensation for the decline of LTP.
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